StockDuty ← Dashboard Sep 01, 2026 07:22 AM ET
CatalystFDA/Bio

GSK TO ADVANCE MRNA SEASONAL FLU VACCINE TO PHASE 3 TRIAL - SEEKINGALPHA

Phase 3 advancement signals regulatory progress and commercial potential for GSK's mRNA flu vaccine.

What changed
Why it matters
Phase 3 advancement signals regulatory progress and commercial potential for GSK's mRNA flu vaccine.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →